Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma — NEJM
Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non–small-cell lung cancer. In this phase 3, open-label study, we randomly assigned previously untreated patients in East...